Preclinical mouse models for immunotherapeutic and non-immunotherapeutic drug development for pancreatic ductal adenocarcinoma
Annals of Pancreatic Cancer · 2020-07 · 3 · 7-7
DOI: 10.21037/apc.2020.03.03 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Pancreatic Cancer, 2020-07. Verfasst von Mengni He und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology, Baltimore, MD, USA. Die Arbeit wurde bisher 37-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cell Biology, Baltimore, MD, USA.
- Department of Oncology, Baltimore, MD, USA.
- The Sidney Kimmel Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
- The Precision Medicine Center of Excellence (PMCoE) Program for Pancreatic Cancer, Baltimore, MD, USA.
Förderung
- NCI NIH HHS
Zitieren
APA
He, M., Henderson, M., Muth, S., Murphy, A., & Zheng, L. (2020). Preclinical mouse models for immunotherapeutic and non-immunotherapeutic drug development for pancreatic ductal adenocarcinoma. Annals of Pancreatic Cancer, 3, 7-7. https://doi.org/10.21037/apc.2020.03.03
Vancouver
He M, Henderson M, Muth S, Murphy A, Zheng L. Preclinical mouse models for immunotherapeutic and non-immunotherapeutic drug development for pancreatic ductal adenocarcinoma. Annals of Pancreatic Cancer. 2020;3:7-7. doi:10.21037/apc.2020.03.03
BibTeX
@article{He2020,
author = {He, Mengni and Henderson, MacKenzie and Muth, Stephen and Murphy, Adrian and Zheng, Lei},
title = {Preclinical mouse models for immunotherapeutic and non-immunotherapeutic drug development for pancreatic ductal adenocarcinoma},
journal = {Annals of Pancreatic Cancer},
year = {2020},
volume = {3},
pages = {7--7},
doi = {10.21037/apc.2020.03.03}
}
EUVIMED